Peking University First Hospital Ethics Committee
Peking University First Hospital Ethics Committee
Beijing, Beijing Municipality, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC Patients | Advanced Non-squamous Non-small-cell Lung Cancer; Metastatic Non-squamous Non Small Cell Lung Cancer; Recurrent Non-Squamous Non-Small Cell Lung Cancer | Not yet recruiting | Phase 2 | 2023-09-13 | NCT06028633 |